These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17766014)

  • 21. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
    Ge W; Li Y; Li ZS; Zhang SH; Sun YJ; Hu PZ; Wang XM; Huang Y; Si SY; Zhang XM; Sui YF
    Cancer Immunol Immunother; 2009 Feb; 58(2):201-8. PubMed ID: 18523770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies.
    Bolhassani A; Zahedifard F; Taghikhani M; Rafati S
    Vaccine; 2008 Jun; 26(26):3362-70. PubMed ID: 18471945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virosomes: a flu jab for malaria?
    Cavanagh DR; Remarque EJ; Sauerwein RW; Hermsen CC; Luty AJ
    Trends Parasitol; 2008 Sep; 24(9):382-5. PubMed ID: 18684667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses.
    Perrin-Cocon L; Agaugué S; Coutant F; Saint-Mézard P; Guironnet-Paquet A; Nicolas JF; André P; Lotteau V
    Vaccine; 2006 Feb; 24(9):1254-63. PubMed ID: 16229929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV).
    Glück R; Wälti E
    Dev Biol (Basel); 2000; 103():189-97. PubMed ID: 11214236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-like particles: designing an effective AIDS vaccine.
    Young KR; McBurney SP; Karkhanis LU; Ross TM
    Methods; 2006 Sep; 40(1):98-117. PubMed ID: 16997718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunobiology of the Tomatine adjuvant.
    Morrow WJ; Yang YW; Sheikh NA
    Vaccine; 2004 Jun; 22(19):2380-4. PubMed ID: 15193398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H; Wang S; Zhang D; Hou S; Qian W; Li B; Guo H; Kou G; He J; Wang H; Guo Y
    Clin Cancer Res; 2009 Jul; 15(14):4612-21. PubMed ID: 19584156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression.
    Bins AD; Jorritsma A; Wolkers MC; Hung CF; Wu TC; Schumacher TN; Haanen JB
    Nat Med; 2005 Aug; 11(8):899-904. PubMed ID: 15965482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells.
    Wang J; Su B; Ding Z; Du X; Wang B
    Biochem Biophys Res Commun; 2008 Aug; 372(3):491-6. PubMed ID: 18502198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous antigenic stimulation system (CASS) as a new immunization strategy.
    Gomez-Vargas A; Rosenthal KL; McDermott MR; Hortelano G
    Vaccine; 2004 Sep; 22(29-30):3902-10. PubMed ID: 15364438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole blood assessment of antigen specific cellular immune response by real time quantitative PCR: a versatile monitoring and discovery tool.
    Schultz-Thater E; Frey DM; Margelli D; Raafat N; Feder-Mengus C; Spagnoli GC; Zajac P
    J Transl Med; 2008 Oct; 6():58. PubMed ID: 18925935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reaction of influenza viruses with thymus-dependent lymphocytes].
    Süss J; Schmidt S; Schmidt J
    Allerg Immunol (Leipz); 1982; 28(3):165-73. PubMed ID: 6183963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New vaccines require potent adjuvants like AFPL1 and AFCo1.
    Pérez O; Lastre M; Cabrera O; del Campo J; Bracho G; Cuello M; Balboa J; Acevedo R; Zayas C; Gil D; Mora N; González D; Pérez R; González E; Barberá R; Fajardo EM; Sierra G; Solís RL; Campa C
    Scand J Immunol; 2007; 66(2-3):271-7. PubMed ID: 17635804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A; Mastini C; Rohrbach F; Weth R; Curcio C; Burkhardt U; Jäger E; Forni G; Cavallo F; Wels WS
    Clin Cancer Res; 2008 Nov; 14(21):6933-43. PubMed ID: 18980988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.
    Zhang S; Zhang H; Shi H; Yu X; Kong W; Li W
    Hum Immunol; 2008; 69(4-5):250-8. PubMed ID: 18486759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.